Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Sandy Liu"'
Autor:
John Nikitas, Andrei Gafita, Matthias R. Benz, Loïc Djaïleb, Andrea Farolfi, Masatoshi Hotta, Ida Sonni, Rejah Alano, Matthew Rettig, John Shen, Wesley Armstrong, Tristan Grogan, Sandy Liu, Johannes Czernin, Jeremie Calais
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract For prostate cancer patients who experience biochemical progression during androgen deprivation therapy (ADT), prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has not been prospectively compa
Externí odkaz:
https://doaj.org/article/2d25a6d37a594d7b82be5f6b5ab994d5
Autor:
Stephanie M. Yoon, Robert Suh, Fereidoun Abtin, Drew Moghanaki, Scott Genshaft, Mitchell Kamrava, Alexandra Drakaki, Sandy Liu, Puja Venkat, Alan Lee, Albert J. Chang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Centrally located lung tumors present treatment challenges given their proximity to mediastinal structures including the central airway, esophagus, major vessels, and heart. Therapeutic options can be limited for medically inopera
Externí odkaz:
https://doaj.org/article/774901fed6d54a3da825ceae436d7b82
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
While localized penile cancers are typically treated surgically and metastatic penile cancers benefit from standard chemotherapy, there have been studies on the horizon demonstrating immunotherapy as a novel approach to metastatic penile cancers that
Externí odkaz:
https://doaj.org/article/24fe8f0453054d3da640efe4961c8e0b
Autor:
Hung Pham, Chiara Birtolo, Chintan Chheda, Wendy Yang, Maria Rodriguez, Sandy Liu, Gabriele Gugliotta, Michael Lewis, Vincenzo Cirulli, Stephen Pandol, Andrzej Ptasznik
Publikováno v:
Frontiers in Physiology, Vol 7 (2016)
Fibrotic disorders involve replacement of normal parenchyma with myofibroblasts, which deposit connective tissue, leading to obliteration of the function of the underlying organ. The treatment options are inadequate and reflect the fact that signalin
Externí odkaz:
https://doaj.org/article/8a7230bd9955468b915e3a83c65745c7
Autor:
Sandy Liu, Radu M Cadaneanu, Baohui Zhang, Lihong Huo, Kevin Lai, Xinmin Li, Colette Galet, Tristan R Grogan, David Elashoff, Stephen J Freedland, Matthew Rettig, William J Aronson, Beatrice S Knudsen, Michael S Lewis, Isla P Garraway
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0163232 (2016)
BACKGROUND:Benign human prostate tubule-initiating cells (TIC) and aggressive prostate cancer display common traits, including tolerance of low androgen levels, resistance to apoptosis, and microenvironment interactions that drive epithelial budding
Externí odkaz:
https://doaj.org/article/fcc8a83a93a242e3b01007102b9f9510
Autor:
Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N. Diamantopoulos, Tanya Jindal, Naomi Vather-Wu, Yousef Zakharia, Nishita Tripathi, Neeraj Agarwal, Scott Dawsey, Shilpa Gupta, Eric Lu, Alexandra Drakaki, Sandy Liu, Roubini Zakopoulou, Aristotelis Bamias, Claudia-Maria Fulgenzi, Alessio Cortellini, David Pinato, Pedro Barata, Petros Grivas, Ali Raza Khaki, Vadim S. Koshkin
Publikováno v:
Clinical Genitourinary Cancer. 21:286-294
To examine patient and disease characteristics, toxicity, and clinical outcomes for patients with advanced urothelial carcinoma (aUC) who are rechallenged with immune checkpoint inhibitor (ICI)-based therapy.In this retrospective cohort, we included
Autor:
Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N. Diamantopoulos, Scott Dawsey, Shilpa Gupta, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet A. Bilen, Tyler F. Stewart, Rana R. McKay, Nishita Tripathi, Neeraj Agarwal, Naomi Vather-Wu, Yousef Zakharia, Rafael Morales-Barrera, Michael E. Devitt, Alessio Cortellini, Claudia Angela Maria Fulgenzi, David J. Pinato, Ariel Nelson, Christopher J. Hoimes, Kavita Gupta, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Jure Murgic, Ana Fröbe, Alejo Rodriguez-Vida, Alexandra Drakaki, Sandy Liu, Eric Lu, Vivek Kumar, Giuseppe Di Lorenzo, Monika Joshi, Pedro Isaacsson-Velho, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Albert Jang, Pedro Barata, Guru Sonpavde, Evan Y. Yu, Robert Bruce Montgomery, Petros Grivas, Ali Raza Khaki
Publikováno v:
Clin Genitourin Cancer
Clinical genitourinary cancer, vol 20, iss 5
Clinical genitourinary cancer, vol 20, iss 5
Immune checkpoint inhibitors are a well-established treatment option for advanced urothelial carcinoma, and biomarkers of response are needed for better patient selection. We show that metastatic disease confined to lymph nodes is associated with bet
Autor:
Hedyeh Ebrahimi, Daniela V. Castro, Matthew I. Feng, Sweta R. Prajapati, Kyle O. Lee, Elyse H. Chan, Trishita Paul, Ishaan Sehgal, Jalen Patel, Xiaochan Li, Zeynep B. Zengin, Luis Meza, Benjamin D. Mercier, JoAnn Hsu, Ameish Govindarajan, Neal Chawla, Nazli Dizman, Cristiane D Bergerot, Adam Rock, Sandy Liu, Abhishek Tripathi, Tanya Dorff, Sumanta K. Pal, Alexander Chehrazi-Raffle
Publikováno v:
Clinical Genitourinary Cancer.
PDF file - 40K, Supplemental Table 1. Selected Demographic and Baseline Characteristics of the Patients. Supplemental Table 2. Selected Demographic and Baseline Characteristics of the HPV16 positive.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499dff7b8e7547f561baaad7be84e8b0
https://doi.org/10.1158/1940-6207.22524665.v1
https://doi.org/10.1158/1940-6207.22524665.v1
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Purpose:Glutaminase is a key enzyme, which supports elevated dependency of tumors on glutamine-dependent biosynthesis of metabolic intermediates. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus plus the oral glutam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a186504f410b1b44c1a1931aa5a0590
https://doi.org/10.1158/1078-0432.c.6532388
https://doi.org/10.1158/1078-0432.c.6532388